← Leaderboards
John F Oram
University Of Washington
$8,126,326
Attributed
$8,126,326
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $832.9K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$8,126,326 · 6
By mechanism
R01$4,795,686 · 3
P01$3,330,640 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Jay W Heinecke$34,087,651
- Chongren Tang$2,168,475
- Peter S Rabinovitch$49,936,459
- Renee C Leboeuf$13,817,725
- April Stempien-Otero$2,045,347
Others in their field
Top investigators on “Cholesterol”
- Leon J Thal · University Of California San Diego$54,467,813
- Daniel James Rader · University Of Pennsylvania$44,733,174
- Alan Richard Tall · Columbia University Health Sciences$38,760,184
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$38,718,698
- Ronald M Krauss · University Of Calif-Lawrenc Berkeley Lab$34,107,220
- Stanley L Hazen · Cleveland Clinic Foundation$28,886,562
Research focus
CholesterolHigh Density LipoproteinsAtherosclerosisApolipoproteinsPhospholipidsLipid TransportMacrophageOxidationHuman SubjectLaboratory MouseClinical ResearchCardiovascular DiseasesInsightMouse ModelPropertyIn VivoCellsGenetically Modified AnimalsPathway InteractionsLipidsProteinsMediatingProgramsAtherogenesis
Grant awards (25)
Reverse Cholesterol Transport in Diabetes$417,873
P01 · FY2012 · HL · contact PI
Reverse Cholesterol Transport in Diabetes$417,872
P01 · FY2011 · HL · contact PI
Reverse Cholesterol Transport in Diabetes$417,872
P01 · FY2010 · HL · contact PI
Reverse Cholesterol Transport in Diabetes$417,872
P01 · FY2009 · HL · contact PI
Anti-inflammatory, cholesterol export, and cardioprotective functions of ABCA1$415,000
R01 · FY2009 · HL · contact PI
Reverse Cholesterol Transport in Diabetes$417,867
P01 · FY2008 · HL · contact PI
Atherogenic Effects of Oxidized High Density Lipoproteins$378,690
R01 · FY2008 · HL · contact PI
Atherogenic Effects of Oxidized High Density Lipoproteins$378,690
R01 · FY2007 · HL · contact PI
Modulation of ABCA1 Expression and Activity$359,362
R01 · FY2007 · HL · contact PI
Atherogenic Effects of Oxidized High Density Lipoproteins$388,750
R01 · FY2006 · HL · contact PI
Modulation of ABCA1 Expression and Activity$370,094
R01 · FY2006 · HL · contact PI
Modulation of ABCA1 Expression and Activity$379,000
R01 · FY2005 · HL
Modulation of ABCA1 Expression and Activity$379,000
R01 · FY2004 · HL
Atherogenic Effects of Tyrosine Oxidation in HDL$341,100
R01 · FY2004 · HL
CELLULAR DISORDERS IN FAMILIAL HDL DEFICIENCIES$342,000
R01 · FY2003 · HL
CELLULAR DISORDERS IN FAMILIAL HDL DEFICIENCIES$342,000
R01 · FY2002 · HL
APOLIPOPROTEIN CELLULAR INTERACTIONS IN VASCULAR BIOLOGY$266,433
P01 · FY2002 · HL
REVERSE CHOLESTEROL TRANSPORT IN DIABETES$130,479
P01 · FY2002 · DK
Reverse Cholesterol Transport in Diabetes$0
P01 · FY2002 · DK
CELLULAR DISORDERS IN FAMILIAL HDL DEFICIENCIES$342,000
R01 · FY2001 · HL
APOLIPOPROTEIN CELLULAR INTERACTIONS IN VASCULAR BIOLOGY$266,433
P01 · FY2001 · HL
REVERSE CHOLESTEROL TRANSPORT IN DIABETES$130,479
P01 · FY2001 · DK
CELLULAR DISORDERS IN FAMILIAL HDL DEFICIENCIES$380,000
R01 · FY2000 · HL
APOLIPOPROTEIN CELLULAR INTERACTIONS IN VASCULAR BIOLOGY$266,433
P01 · FY2000 · HL
REVERSE CHOLESTEROL TRANSPORT IN DIABETES$181,027
P01 · FY2000 · DK